Lipoprotein(a) level associates with coronary artery disease rather than carotid lesions in patients with familial hypercholesterolemia
Authors:
Open Access
- 30 March 2018
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 32 (7) , e22442
Abstract
Background: Lipoprotein(a) [Lp(a)] level is a novel risk factor for atherosclerotic cardiovascular disease in patients with familial hypercholesterolemia (FH), while its impact on the different sites of arteries remains undetermined. We aim to examine the associations of Lp(a) levels with coronary and carotid atherosclerosis in patients with heterozygous FH (HeFH).Methods: A total of 148 patients with HeFH who have received carotid ultrasonography and coronary angiography due to chest pain were enrolled. Plasma Lp(a) was measured using immunoturbidimetric method. Finally, the associations between Lp(a) and coronary as well as carotid lesions were evaluated.Results: Patients with Lp(a) ≥ 300 mg/L had similar carotid intima‐media thickness (IMT, 0.782 ± 0.16 mm vs 0.798 ± 0.18 mm, P = .579) and plaque prevalence (66.7% vs 65%, P = .833) compared to those with Lp(a) < 300 mg/L, but had a higher prevalence of coronary artery disease (CAD, 69.7% vs 50.0%, P = .016) and higher Gensini score (GS, median 27 vs 3, P = .006). Moreover, no correlations were found between carotid mean IMT with either Lp(a) level or Lp(a) year score, while positive relation of Lp(a) with GS did. Multivariate regression analysis revealed that Lp(a), Lp(a) year score, and Lp(a) ≥ 300 g/L were all independent predictors for the presence of CAD (OR = 4.99, P = .007; OR = 4.73, P = .009; OR = 4.46, P = .006, respectively) but not for carotid plaques.Conclusions: This study suggested that Lp(a) level was associated with the presence and severity of CAD but not with carotid atherosclerosis in patients with HeFH.Keywords
Funding Information
- Capital Health Development Fund (201614035)
- CAMS Major Collaborative Innovation Project (2016-I2M-1-011)
This publication has 33 references indexed in Scilit:
- Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery diseaseAtherosclerosis, 2017
- Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary AngiographyArteriosclerosis, Thrombosis, and Vascular Biology, 2017
- Lipoprotein (a) is a risk factor for coronary artery disease in Chinese Han ethnic population modified by some traditional risk factors: A cross-sectional study of 3462 cases and 6125 controlsClinica Chimica Acta, 2015
- Lipoprotein (a) as a risk factor for ischemic stroke: A meta-analysisAtherosclerosis, 2015
- Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemiaAtherosclerosis, 2015
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Coronary and carotid atherosclerosis: Similarities and differencesAtherosclerosis, 2013
- Lipoprotein(a) predicts progression of carotid artery intima-media thickening in patients with type 2 diabetes: A four-year follow-upWiener klinische Wochenschrift, 2010
- Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General PopulationCirculation, 2008
- Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Heterozygous Familial HypercholesterolemiaClinical Chemistry, 2005